Literature DB >> 15160988

Cardiotoxic drugs in breast cancer.

Alper Sevinc, Suleyman Buyukberber, Celalettin Camci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15160988      PMCID： PMC2640667     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  5 in total

1.  Cardiotoxicity associated with paclitaxel/trastuzumab combination therapy.

Authors:  S Jerian; P Keegan
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

2.  Paclitaxel and cardiotoxicity.

Authors:  E A Perez
Journal:  J Clin Oncol       Date:  1998-11       Impact factor: 44.544

3.  A clinicopathologic analysis of adriamycin cardiotoxicity.

Authors:  E A Lefrak; J Pitha; S Rosenheim; J A Gottlieb
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

4.  Cardiotoxicity in patients receiving transtuzumab (Herceptin): primary toxicity, synergistic or sequential stress, or surveillance artifact?

Authors:  M S Ewer; H R Gibbs; J Swafford; R S Benjamin
Journal:  Semin Oncol       Date:  1999-08       Impact factor: 4.929

5.  Doxorubicin cardiotoxicity in African Americans.

Authors:  Syed Hasan; Kimberly Dinh; Fred Lombardo; John Kark
Journal:  J Natl Med Assoc       Date:  2004-02       Impact factor: 1.798
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.